February 27, 2026

161: Clinical Takeaways From 2026 International Stroke Conference

28 minutes

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.

In this special Mind Moments episode, Lauren Sansing, MD, MS, FAHA, FANA, Professor of Neurology at Yale School of Medicine, joins the podcast to provide a clinical breakdown of the 2026 International Stroke Conference and its implications for real-world stroke care. Sansing reflects on how this year’s meeting built on prior advances, highlighting expanded global collaboration, greater patient engagement, and a record number of clinical trials presented. The discussion explores which late-breaking studies may influence practice in the coming year, including data on secondary stroke prevention, adjunctive thrombolysis strategies, and evolving patient selection for thrombectomy in extended windows and large core infarcts. Sansing also reviews renewed momentum in neuroprotection research, key updates from the newly released acute ischemic stroke guidelines, emerging pediatric stroke data, and how the conference continues to shape the roadmap for 2027 and beyond.

Looking for more Stroke discussion? Check out the NeurologyLive® Stroke clinical focus page.

Episode Breakdown:

1:00 – Biggest moments and structural evolution of ISC 2026

3:15 – Presented practice-changing trial data impacting stroke care

7:05 – Thrombectomy strategy and extended window patient selection

10:40 – Renewed momentum in neuroprotection research

15:20 – Neurology News Network

17:40 – Key updates from the new acute ischemic stroke guidelines

25:00 – A brief look-ahead to ISC 2027

The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:

PTC Withdraws Ataluren Submission as Treatment for Nonsense Mutation Duchenne Muscular Dystrophy

Microbiome-Targeted Agent PLL001 Passes Safety Check in Phase 1/2 Trial of ALS

Rimegepant Displays Safety and Efficacy in Study of Adolescents With Migraine

Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

...more

View all episodes

By NeurologyLive

4.6

1010 ratings